CTC Capital Management’s CVS Health CVS Stock Holding History

CTC Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,100	Closed	-$473K	–	129
2022 Q2	$473K	Buy	+5,100	New	+$498K	0.51%	35

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CTC Capital Management's CVS Position: Q3 2022 in Review

CTC Capital Management sold out of CVS Health (CVS) in Q3 2022, closing a stake of 5,100 shares — an estimated $473K sold.

CTC Capital Management first reported a position in CVS in Q2 2022 and held it in 1 quarter. The position peaked at $473K in Q2 2022. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

CTC Capital Management reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
CTC Capital Management sold 5,100 CVS Health shares in Q3 2022, an estimated $473K.
CTC Capital Management first reported a position in CVS Health in Q2 2022 and held it in 1 quarter.
CTC Capital Management's CVS Health position peaked at $473K in Q2 2022.
2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on CTC Capital Management's 13F filing for Q3 2022, filed 20 Oct 2022.